Annexon Inc (NAS:ANNX)
$ 5.34 0.05 (0.95%) Market Cap: 569.21 Mil Enterprise Value: 258.70 Mil PE Ratio: 0 PB Ratio: 1.70 GF Score: 42/100

Annexon Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 11, 2022 / 07:45PM GMT
Release Date Price: $2.57 (-0.77%)
Joey Stringer
Needham & Company - Analyst

Good afternoon, everyone. Thank you for joining the 21st annual Needham healthcare conference. My name is Joey Stringer and I am one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Annexon Biosciences. Joining us today from Annexon is President and CEO Doug love.

For those of you joining us on the webcast, if you wish to ask a question, please do so at any time. You can submit a question using the chat box at the bottom of your screen. So, with that we'll go ahead and get started. I'll turn it over to Doug for some brief opening remarks and then we'll go ahead and start with the chat.

Doug Love
Annexon, Inc. - CEO

Thanks so much, Joey. Really appreciate you and Needham having Annexon and myself with you this afternoon. Really excited about where we are as a company at this stage. I think you all are aware, we're focused on the classical pathway. And we are squarely in Phase 2/Phase 3 studies in multiple indications spanning autoimmune,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot